MX354741B - Composicion antibacterial de timol y totarol. - Google Patents

Composicion antibacterial de timol y totarol.

Info

Publication number
MX354741B
MX354741B MX2014007133A MX2014007133A MX354741B MX 354741 B MX354741 B MX 354741B MX 2014007133 A MX2014007133 A MX 2014007133A MX 2014007133 A MX2014007133 A MX 2014007133A MX 354741 B MX354741 B MX 354741B
Authority
MX
Mexico
Prior art keywords
totarol
thymol
antibacterial composition
synergistic effect
positive bacteria
Prior art date
Application number
MX2014007133A
Other languages
English (en)
Other versions
MX2014007133A (es
Inventor
Hourigan Regina
Gafur Rehana
Mattai Jairajh
Masters James
Du-Thumm Laurence
Pilch Shira
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2014007133A publication Critical patent/MX2014007133A/es
Publication of MX354741B publication Critical patent/MX354741B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Se revela una composición antibacterial que comprende timol y totarol. Esta combinación proporciona un efecto sinérgico en contra de las bacterias gram negativas y gram positivas.
MX2014007133A 2011-12-15 2011-12-15 Composicion antibacterial de timol y totarol. MX354741B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/065024 WO2013089721A1 (en) 2011-12-15 2011-12-15 Thymol and totarol antibacterial composition

Publications (2)

Publication Number Publication Date
MX2014007133A MX2014007133A (es) 2014-09-04
MX354741B true MX354741B (es) 2018-03-16

Family

ID=45524939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007133A MX354741B (es) 2011-12-15 2011-12-15 Composicion antibacterial de timol y totarol.

Country Status (11)

Country Link
US (1) US9832994B2 (es)
EP (1) EP2790504B1 (es)
KR (1) KR20140104011A (es)
CN (1) CN103974617B (es)
AU (1) AU2011383313B2 (es)
BR (1) BR112014014036B1 (es)
CA (1) CA2859519C (es)
MX (1) MX354741B (es)
PH (1) PH12014501239A1 (es)
RU (1) RU2563208C1 (es)
WO (1) WO2013089721A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013108870A1 (de) * 2013-08-16 2015-02-19 Aimecs Gmbh Mittel zur Reinigung und zum Schutz von technischen Oberflächen
CN104027260A (zh) * 2014-06-20 2014-09-10 广州薇美姿个人护理用品有限公司 一种含有桃柘酚的口腔护理用品
CN104664551A (zh) * 2015-01-19 2015-06-03 吉林大学 一种抑制金黄色葡萄球菌外毒素分泌的抑制剂
KR101706284B1 (ko) 2015-03-10 2017-03-15 주식회사 불스원 훈증형 항균 조성물 및 이를 포함하는 훈증기
PL236429B1 (pl) * 2017-07-06 2021-01-11 Emergopharm Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa Zastosowanie totarolu do wytwarzania preparatu do leczenia bakteryjnego zakażenia pochwy i kompozycja farmaceutyczna do zastosowania w leczeniu stanów zapalnych pochwy o podłożu bakteryjnym

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002451B (el) 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
CN1249929A (zh) * 1998-10-07 2000-04-12 逻辑技术国际公司 抗菌组合物
SE9901733L (sv) 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
NZ530834A (en) * 2004-01-28 2007-06-29 Owen John Catchpole Near-critical extraction of totarol and/or a product containing totarol
EP1898952B1 (en) 2005-06-17 2012-09-12 Symrise AG Synergistic mixtures of aromatic alcohols and derivatives thereof with tropolone
US20090312279A1 (en) 2005-12-23 2009-12-17 Sterilex Technologies, Llc Antimicrobial compositions
US20070258996A1 (en) 2005-12-23 2007-11-08 The Sterilex Corporation Antimicrobial compositions
US20080194518A1 (en) 2005-12-23 2008-08-14 MOOKERJEE Pradip Antimicrobial Compositions
US20090324517A1 (en) * 2008-06-30 2009-12-31 Dan Kline Halitosis treatment
GB0813323D0 (en) 2008-07-21 2008-08-27 Campbell Donald Antimicrobial compositions and methods
CN102186341B (zh) * 2008-10-20 2013-12-25 荷兰联合利华有限公司 抗菌组合物
GB2471135A (en) 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
JP5471335B2 (ja) * 2009-11-17 2014-04-16 ライオン株式会社 口腔バイオフィルム殺菌剤

Also Published As

Publication number Publication date
US20140314689A1 (en) 2014-10-23
PH12014501239A1 (en) 2014-09-08
WO2013089721A1 (en) 2013-06-20
AU2011383313A1 (en) 2014-06-19
CN103974617A (zh) 2014-08-06
CN103974617B (zh) 2015-11-25
CA2859519A1 (en) 2013-06-20
EP2790504B1 (en) 2016-03-09
CA2859519C (en) 2016-08-16
BR112014014036B1 (pt) 2018-02-14
MX2014007133A (es) 2014-09-04
US9832994B2 (en) 2017-12-05
BR112014014036A2 (pt) 2017-06-13
RU2563208C1 (ru) 2015-09-20
KR20140104011A (ko) 2014-08-27
AU2011383313B2 (en) 2014-07-31
EP2790504A1 (en) 2014-10-22

Similar Documents

Publication Publication Date Title
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
PH12016501512B1 (en) Treatment for resistant acne
IN2015DN01198A (es)
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
EP3325604A4 (en) BENEFICIAL MICROBES FOR AGRICULTURE, MICROBIAL COMPOSITIONS AND CONSORTIVA
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
PL2685994T3 (pl) Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
MY173518A (en) Antimicrobial compounds and methods of making and using the same
MX354988B (es) Formulaciones de anticuerpo y metodos.
MX2016003482A (es) Composiciones antimicrobianas.
MX2015016319A (es) Terapia de combinacion que comprende oxazolidinona-quinolonas para uso en el tratamiento de infecciones bacterianas.
IN2012DN00374A (es)
GB2548277A (en) Antibiofilm compositions
MX2012001498A (es) Composicion antimicrobiana sinergica.
PH12014501239A1 (en) Thymol and totarol antibacterial composition
EP2995200A4 (en) Sterilization composition with synergism
MX363631B (es) Composiciones y metodos para tratar infecciones bacterianas.
EP2844258A4 (en) METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS
IN2013MU03216A (es)
MX2016005869A (es) Inhibidor de beta-lactamasa cristalina.
MX2011011405A (es) Combinacion sinergica de flumetsulam con tiabendazol.
AU2011902607A0 (en) Animal infection treatment and prophylaxis
AU2012902449A0 (en) Novel animal infection treatment and prophylaxis

Legal Events

Date Code Title Description
FG Grant or registration